MARLBOROUGH – Sartorius Stedim Biotech officially opened its new Center for Bioprocess Innovation in Marlborough.
“The Greater Boston area is home to an unparalleled ecosystem that fosters innovation, collaboration, and growth. As a global hub for biotechnology and life sciences, it offers access to world-renowned academic institutions, cutting-edge research facilities, and a highly skilled workforce. Moreover, the region’s robust network of venture capital firms and industry partnerships provides ample opportunities for strategic collaborations. This is an ideal time and a great place to launch these capabilities which are so critical to the success of our customers,” said President of Sartorius North America Maurice Phelan.
As officials gathered at the new center at 200 Donald Lynch Boulevard on Nov. 21, Phelan noted that they went before the City Council a year prior to discuss the project and work on the tax increment financing agreement.
Phelan thanked Mayor J. Christian Dumais, City Council President Michael Ossing and former Mayor Arthur Vigeant. Dumais said he was happy to support the TIF last year while serving as a member of the City Council.
“The city and [Marlborough Economic Development Corporation] were eager to partner with Sartorius last year … on advancing the TIF to help make this project a reality within Marlborough,” said Dumais.
The Donald Lynch Boulevard center is 63,000 square feet. It includes research and service laboratories and facilities for demonstrations and training for customers. It will be able to accommodate over 120 internal and external bioprocessing experts.
This is the third Sartorius site in Marlborough. The company acquired WaterSep BioSeparations in 2020 and opened a Customer Interaction Center for Bioprocess Equipment in 2021.
Secretary of Economic Development Yvonne Hao recalled that Phelan visited her soon after she assumed the role. The pair talked about the idea for the Marlborough site.
“It is truly impressive to see it come to life,” said Hao.
She said it takes a team effort of Team Massachusetts, Team Sartorius and Team Marlborough to make it happen. Sartorius and the state are doing this work because they care about making the world a better place and helping people live better lives and saving lives, she said.
“Touring these facilities and seeing the work you’re doing, you’re on the cutting edge. … All of these wicked smart people here in this company are doing things to help us accelerate drug discovery, accelerate cures for diseases, making sure that things are safer and better and faster. This is really important work, and this is what we do in Massachusetts,” Hao said.
